机译:F-18-FDG PET / CT在术前化疗预测非心率化化疗的胃癌(GIRCG)经验中的术前化疗后预测肿瘤回归有限
Morgagni Pierantoni Hosp Dept Surg Forli Italy;
Borgo Trento City Hosp Dept Gen &
Upper GI Surg Verona Italy;
Morgagni Pierantoni Hosp Dept Surg Forli Italy;
Borgo Trento City Hosp Dept Gen &
Upper GI Surg Verona Italy;
Borgo Trento City Hosp Dept Gen &
Upper GI Surg Verona Italy;
Morgagni Pierantoni Hosp Dept Surg Forli Italy;
Morgagni Pierantoni Hosp Pathol Unit Forli Italy;
Montevarchi Gen Hosp Santa Maria Gruccia Surg Unit Arezzo Italy;
Perugia Univ Dept Surg Santa Maria Misericordia Perugia Italy;
Perugia Univ Dept Surg Santa Maria Misericordia Perugia Italy;
Humanitas Clin Inst IRCCS Milan Italy;
Univ Hosp Brescia Dept Clin &
Expt Sci Surg Clin Brescia Italy;
Morgagni Pierantoni Hosp Nucl Med Unit Forli Italy;
San Donato Hosp Nucl Med Unit Arezzo Italy;
Univ Verona Unit Epidemiol &
Med Stat Verona Italy;
F-18-FDG PET; CT; gastric cancer; metabolic response; neoadjuvant treatment; pathological response;
机译:F-18-FDG PET / CT在术前化疗预测非心率化化疗的胃癌(GIRCG)经验中的术前化疗后预测肿瘤回归有限
机译:胃癌最大CT缩小率作为CT评估新辅助治疗后组织病理学回归的放射学指标:多中心GIRCG研究
机译:胃癌最大肿瘤直径降低率在CT检查中作为预测Neoadjuvant治疗后的组织病理学回归的放射性指标:多期面GIRCG研究
机译:术前腹膜内化疗,用于血清患者浸润胃癌患者
机译:CD44V9 / XCT作为针对ROS诱导的胃癌化疗的保护机制的作用
机译:多中心GIRCG研究:CT检查时胃癌最大肿瘤直径缩小率作为预测新辅助治疗后组织病理学退化的放射学指标
机译:胃中上三分之一的腺癌的总Vs腹膜切除术:多中心西方经验的倾向分数匹配分析(代表胃癌 - Gircg的意大利研究组)